Eric Lefkofsy is a man with the entrepreneurial spirit. He has founded and co-founded several companies. His mark is on companies like Tempus, Groupon and Uptake Technologies. Tempus is a company that uses its operating system to help fight cancer. The technology they continually update is employed to give doctors additional information from patient studies to fight the dreadful disease. Tempus gathers RNA-seq capture and germline data from patient samples. Around 50,000 patients have their testing results entered into a data base annually. Access to this information is arming doctors with more effective data that could lead to the better treatment of their cancer patients.
With Tempus’ efforts doctor are using the information gathered from the prior treatment of hundreds of patients. Doctors are no longer limited to the information gathered from treating individual patients. The goal of Tempus goal is to give doctors enough reliable treatment knowledge so they can treat patients based on previous successes to insure even more domination over cancer.
The Tempus team all use their knowledge to forge ahead, working to achieve their ultimate goal, domination over cancer. The top team at Tempus has nine leaders that include the co-founder, Eric Lefkofsky; a president; a chief medical officer; a director of pathology; a vice president and general counsel; a senior vice president; a chief operating officer; a chairman; and a scientific advisor.
This team keeps Tempus focused on the task at hand, helping doctors obtain the data they need to analyze a fundamental issue for conquering cancer, the complexities of the genetic code in molecular therapy. Tempus takes genomic sequencing and analyzing it plus its interaction with disease, entering everything into a comprehensive database that doctors can easily access.
Tempus takes the genomic data merging it with statistical analysis to find opportunities to assist physicians in giving effective treatments to cancer patients. Compiling this data in a single secure will make it possible for doctors to offer better care and treatment for the cancer patients. Right now the cancers being evaluated are limited to breast cancer, as well as lung and pancreatic cancer, but the future is bright, because soon every cancer will be represented in Tempus’ database.